PPAR-y	JJ
ligands	NNS
repress	VBP
TGFb-induced	JJ
myofibroblast	NN
differentiation	NN
by	IN
targeting	VBG
the	DT
PI3K/Akt	NN
pathway	NN
:	:
implications	NNS
for	IN
therapy	NN
of	IN
fibrosis	NN
.	.

Transforming-growth-factor-beta	NN
(	(
TGFb	NN
)	)
induced	VBD
differentiation	NN
of	IN
human	JJ
lung	NN
fibroblasts	NNS
to	TO
myofibroblasts	NNS
is	VBZ
a	DT
key	JJ
event	NN
in	IN
the	DT
pathogenesis	NN
of	IN
pulmonary	JJ
fibrosis	NN
.	.

Although	IN
the	DT
typical	JJ
TGFb	NN
signaling	NN
pathway	NN
involves	VBZ
the	DT
Smad	NN
family	NN
of	IN
transcription	NN
factors	NNS
,	,
we	PRP
have	VBP
previously	RB
reported	VBN
that	IN
peroxisome-proliferator-activated-receptor-y	NN
(	(
PPAR-y	NN
)	)
ligands	NNS
inhibit	VBP
TGFb-mediated	JJ
differentiation	NN
of	IN
human	JJ
lung	NN
fibroblasts	NNS
to	TO
myofibroblasts	JJ
via	IN
a	DT
Smad-independent	JJ
pathway	NN
.	.

TGFb	NN
also	RB
activates	VBZ
the	DT
phosphatidylinositol	NN
3	CD
kinase/protein-kinase-B	NN
(	(
PI3K/Akt	NN
)	)
pathway	NN
leading	VBG
to	TO
phosphorylation	NN
of	IN
Akt	NN
(	(
S473	NN
)	)
.	.

Here	RB
,	,
we	PRP
report	VBP
that	IN
PPAR-y	NN
ligands	NNS
,	,
2-cyano-3,12-dioxooleana-1,9-dien-28-oic	JJ
acid	NN
(	(
CDDO	NN
)	)
and	CC
15-deoxy	JJ
-	:
(	(
12,14	CD
)	)
-15	CD
d-prostaglandin	NN
J	NN
(	(
2	CD
)	)
(	(
15d-PGJ	NN
(	(
2	CD
)	)
)	)
,	,
inhibit	VBP
human	JJ
myofibroblast	NN
differentiation	NN
of	IN
normal	JJ
and	CC
idiopathic	JJ
pulmonary	JJ
fibrotic	JJ
(	(
IPF	NN
)	)
fibroblasts	NNS
,	,
by	IN
blocking	VBG
Akt	NN
phosphorylation	NN
at	IN
Ser473	NN
by	IN
a	DT
PPAR-y-independent	JJ
mechanism	NN
.	.

The	DT
PI3K	NN
inhibitor	NN
LY294002	NN
and	CC
a	DT
dominant-negative	JJ
inactive	JJ
kinase-domain	NN
mutant	NN
of	IN
Akt	NN
both	CC
inhibited	VBD
TGFb-stimulated	JJ
myofibroblast	NN
differentiation	NN
,	,
as	IN
determined	VBN
by	IN
Western	NN
blotting	NN
for	IN
a-smooth-muscle-actin	NN
and	CC
calponin	NN
.	.

Prostaglandin	NN
A	NN
(	(
1	CD
)	)
(	(
PGA	NN
(	(
1	CD
)	)
)	)
,	,
a	DT
structural	JJ
analogue	NN
of	IN
15d-PGJ	NN
(	(
2	CD
)	)
with	IN
an	DT
electrophilic	JJ
center	NN
,	,
also	RB
reduced	VBD
TGFb-driven	JJ
phosphorylation	NN
of	IN
Akt	NN
,	,
while	IN
CAY10410	NN
,	,
another	DT
analogue	NN
that	WDT
lacks	VBZ
an	DT
electrophilic	JJ
center	NN
,	,
did	VBD
not	RB
;	:
implying	VBG
that	IN
the	DT
activity	NN
of	IN
15d-PGJ	NN
(	(
2	CD
)	)
and	CC
CDDO	NN
is	VBZ
dependent	JJ
on	IN
their	PRP$
electrophilic	JJ
properties	NNS
.	.

PPAR-y	JJ
ligands	NNS
inhibited	VBD
TGFb-induced	JJ
Akt	NN
phosphorylation	NN
via	IN
both	CC
post-translational	JJ
and	CC
post-transcriptional	JJ
mechanisms	NNS
.	.

This	DT
inhibition	NN
is	VBZ
independent	JJ
of	IN
MAPK-p38	NN
and	CC
PTEN	NN
but	CC
is	VBZ
dependent	JJ
on	IN
TGFb-induced	JJ
phosphorylation	NN
of	IN
FAK	NNP
,	,
a	DT
kinase	NN
that	WDT
acts	VBZ
upstream	RB
of	IN
Akt	NN
.	.

Thus	RB
,	,
PPAR-y	JJ
ligands	NNS
inhibit	VBP
TGFb	NN
signaling	NN
by	IN
affecting	VBG
two	CD
pro-survival	JJ
pathways	NNS
that	WDT
culminate	VBP
in	IN
myofibroblast	NN
differentiation	NN
.	.

Further	JJ
studies	NNS
of	IN
PPAR-y	JJ
ligands	NNS
and	CC
small	JJ
electrophilic	JJ
molecules	NNS
may	MD
lead	VB
to	TO
a	DT
new	JJ
generation	NN
of	IN
anti-fibrotic	JJ
therapeutics	NNS
.	.

